AITEM
AiTEM
AITEM is an AI-driven small-molecule formulation design platform developed by METiS Pharmaceuticals (剂泰科技), one of three core technology solutions built on the company's NanoForge foundation alongside AiLNP and AiRNA . The platform uses artificial intelligence to substantially shorten drug development timelines while improving safety and efficacy . METiS Pharmaceuticals, which listed on the Hong Kong Stock Exchange in May 2026 as the world's first AI drug delivery stock, had independently developed AITEM as of mid-2024 before its IPO .elsewhere's corpus does not cover this subject in depth beyond its relationship to METiS Pharmaceuticals.
AI-generated — may contain errors, please verify.
Coverage
5Y News | Congratulations to METiS Pharmaceuticals on its Hong Kong Stock Exchange listing!
METiS Pharmaceuticals, the world's first publicly listed AI-driven drug delivery company, goes public, ushering in a new era for biopharmaceuticals.
Heart Capital Congratulates METiS Pharmaceuticals on Successful Listing on the Main Board of the Hong Kong Stock Exchange | Heart Star PORTFOLIO
The world's first publicly listed AI drug delivery company.
Code Moment | Congratulations to METiS Pharmaceuticals on Its HKEX Listing, the World's First AI Drug Delivery Stock
Source Code Capital participated in METiS Pharmaceuticals' angel round in 2020 and continued to increase its stake in subsequent rounds.
MaKe | MaHui Member METiS Pharmaceuticals Closes $100 Million Series C, Leading the "AI + Drug Delivery" Track
5Y News | 5Y Capital Portfolio Company METiS Pharmaceuticals Closes $100 Million Series C Round
Focused on "AI-powered drug delivery."
